Scotia Holdings PLC
Patent Applications and Registrations
Patent applications and USPTO patent grants for Scotia Holdings PLC.The latest application filed is for "diagnostic test for schizophrenia, using niacin".
- Scotia Holdings PLC -
- Scotia Holdings PLC. - Surrey GB
- Scotia Holdings PLC - Scotland GB
- Scotia Holdings plc - Stirling GB
- Scotia Holdings PLC. - Peasmarsh GB
- Scotia Holdings PLC - Surrey GB
- Scotia Holdings Plc - GB GB
- Scotia Holdings PLC - GB2 GB2
- Scotia Holdings plc - Guildford GB
Trademarks
| Patent | Date |
|---|---|
| Diagnostic test for schizophrenia, using niacin App 20040071762 - Glen, Alexander Iain Munro ; et al. | 2004-04-15 |
| Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid App 20040048927 - Horrobin, David Frederick | 2004-03-11 |
| Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid App 20040014810 - Horrobin, David Frederick | 2004-01-22 |
| Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid Grant 6,624,195 - Horrobin September 23, 2 | 2003-09-23 |
| Polyethylene glycol esters of polyunsaturated fatty acids Grant 6,610,740 - Wakefield , et al. August 26, 2 | 2003-08-26 |
| 1,3-propane diol esters and ethers and methods for their use in drug delivery Grant 6,555,700 - Horrobin , et al. April 29, 2 | 2003-04-29 |
| Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid App 20030045578 - Horrobin, David Frederick | 2003-03-06 |
| Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid App 20020065319 - Horrobin, David Frederick | 2002-05-30 |
| Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid Grant 6,331,568 - Horrobin December 18, 2 | 2001-12-18 |
| Fatty acid esters as bioactive compounds Grant 6,245,811 - Horrobin , et al. June 12, 2 | 2001-06-12 |
| Methods of treatment using ascorbyl gamma linolenic acid or ascorbyl dihomo-gamma-linolenic acid Grant 6,177,470 - Horrobin , et al. January 23, 2 | 2001-01-23 |
| Compositions for treatment of diabetic complications Grant 6,069,168 - Horrobin , et al. May 30, 2 | 2000-05-30 |
| Fatty acid treatment Grant 5,888,541 - Horrobin , et al. March 30, 1 | 1999-03-30 |
| Stabilization of polyunsaturates Grant 5,871,757 - Cloughley , et al. February 16, 1 | 1999-02-16 |
| Triglycerides Grant 5,866,703 - Horrobin , et al. February 2, 1 | 1999-02-02 |
| Fatty acid derivatives Grant 5,847,000 - Horrobin , et al. December 8, 1 | 1998-12-08 |
| Fatty acid treatment Grant 5,837,731 - Vaddadi November 17, 1 | 1998-11-17 |
| Lipids for treatment of disease Grant 5,763,484 - Horrobin June 9, 1 | 1998-06-09 |
| Triglycerides of fatty acids Grant 5,670,540 - Horrobin , et al. September 23, 1 | 1997-09-23 |
| Fatty acid treatment Grant 5,618,558 - Horrobin , et al. April 8, 1 | 1997-04-08 |
| Fatty acid derivatives Grant 5,603,959 - Horrobin , et al. February 18, 1 | 1997-02-18 |
| Fatty acid treatment for ectopic calcium deposition Grant 5,516,801 - Horrobin , et al. May 14, 1 | 1996-05-14 |
| Schizophrenia Grant 5,516,800 - Horrobin May 14, 1 | 1996-05-14 |
| Formulations containing unsaturated fatty acids Grant 5,466,841 - Horrobin , et al. November 14, 1 | 1995-11-14 |
| Method of treating vulvar dystrophy and vaginal dryness Grant 5,380,757 - Horrobin January 10, 1 | 1995-01-10 |
| Lithium salt-containing pharmaceutical compositions Grant 5,252,333 - Horrobin * October 12, 1 | 1993-10-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 